Synergy Spine Solutions, a Louisville, CO-based medical device developer, raised $30M in funding.
The round was led by Amzak Health, with participation from other investors. With this investment, Joyce Erony of Amzak Health has joined Synergy’s Board of Directors.
The company intends to use the funds to complete enrollment of its U.S. IDE 2-level clinical trial, continue patient follow-up on both the 1-level and 2-level clinical trials, submit anticipated Pre-Market Approval applications to the FDA, as well as to support continued commercialization in markets outside the United States.
Led by CEO Josh Butters, Synergy Spine Solutions works to identify and commercialize spine technologies that help surgeons improve their patients’ quality of life and advance the standard of care. Its flagship product, the Synergy Disc®, is a device designed to restore both motion and alignment to the spine.
Commenting on the news, Josh Butters said: “We look forward to welcoming Amzak Health to the Synergy team that has worked incredibly hard to get to this point. We remain focused on completing the 2-level study and to bringing the Synergy Disc® to the U.S. market, as it represents an important treatment option for patients suffering from degenerative disc disease and was specifically designed to restore both motion and alignment to the cervical spine.”